Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Boehringer Ingelheim
Harvard Business School
Federal Trade Commission

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017016

« Back to Dashboard

NDA 017016 describes CHORIONIC GONADOTROPIN, which is a drug marketed by Bel Mar, Ferring, and Fresenius Kabi Usa, and is included in three NDAs. It is available from two suppliers. Additional details are available on the CHORIONIC GONADOTROPIN profile page.

The generic ingredient in CHORIONIC GONADOTROPIN is gonadotropin, chorionic. Four suppliers are listed for this compound. Additional details are available on the gonadotropin, chorionic profile page.
Summary for 017016
Ingredient:gonadotropin, chorionic
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 017016
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CHORIONIC GONADOTROPIN gonadotropin, chorionic INJECTABLE;INJECTION 017016 NDA Ferring Pharmaceuticals Inc. 55566-1501 N 55566-1501-1
CHORIONIC GONADOTROPIN gonadotropin, chorionic INJECTABLE;INJECTION 017016 NDA Ferring Pharmaceuticals Inc. 55566-1502 N 55566-1502-1

Profile for product number 004

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength20,000 UNITS/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 006

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength5,000 UNITS/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Profile for product number 007

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength10,000 UNITS/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Chinese Patent Office
Argus Health
Federal Trade Commission
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.